- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00937742
The Effect of Processed Tomato Products on CVD Risks (TOMATO)
August 16, 2023 updated by: Penn State University
The Effect of Processed Tomatoes on Endothelium- and Platelet- Function
The primary working hypothesis is that consuming processed tomatoes frequently/daily will favorably improve endothelium and platelet function disease-risk biomarker profiles in adult men and women compared to consuming no or relatively low amounts of processed tomatoes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Penn State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
men and women (>21 <70 years) nonsmokers, with a body mass index (BMI) ranging of 25 to 35 kg/m2, BP < or = 140/90 mmHg
Exclusion Criteria:
- Total cholesterol (TC) is greater than 300 mg/dL;
- Fasting triglyceride is greater than 300 mg/dL;
- LDL cholesterol (LDL-C) is greater than 180 mg/dL;
- Female subjects who are pregnant or lactating;
- Subjects who are actively losing weight or trying to lose weight;
- Subjects with known allergy or intolerance to tomato products;
- taking any medications that would interfere with outcomes of the study, ie. lipid lowering medications, anti-inflammatory drugs, dietary supplements, such as fish oil or evening primrose;
- subjects' with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, uncontrolled hypertension (>=140/90 mm Hg - ok if controlled below this limit with medication), or other systemic diseases;
- subjects with low hematological counts as determined by >or <15% the upper or lower cut-off values of normal established for the lab;
- Smokers. -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-tomato products
Non-tomato products (i.e.
teriyaki marinade, sprite, applesauce) to be consumed daily in replace of tomato products
|
Specified amounts of tomato products (i.e.
tomato juice, ketchup, salsa, tomato soup, spaghetti sauce) to be consumed daily during a 6 week intervention phase.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Platelet and monocyte function/activity
Time Frame: Baseline and end of intervention phase (week 6)
|
Baseline and end of intervention phase (week 6)
|
Vascular function
Time Frame: Baseline and end of intervention phase (week 6)
|
Baseline and end of intervention phase (week 6)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Lipids
Time Frame: Baseline and end of intervention phase (week 6)
|
Baseline and end of intervention phase (week 6)
|
Insulin/Glucose
Time Frame: Baseline and end of intervention phase (week 6)
|
Baseline and end of intervention phase (week 6)
|
Inflammatory Markers
Time Frame: Baseline and end of intervention phase (week 6)
|
Baseline and end of intervention phase (week 6)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Penny M Kris-Etherton, PhD, Penn State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
September 1, 2008
Study Completion (Actual)
April 1, 2009
Study Registration Dates
First Submitted
July 10, 2009
First Submitted That Met QC Criteria
July 10, 2009
First Posted (Estimated)
July 13, 2009
Study Record Updates
Last Update Posted (Actual)
August 21, 2023
Last Update Submitted That Met QC Criteria
August 16, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PKE TOMATO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
-
Penn State UniversityAlmond Board of California; The Hershey CompanyCompletedCardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentCompleted
-
Aziyo Biologics, Inc.CompletedCardiovascular DiseaseUnited States
-
Monash UniversityCompletedCardiovascular DiseaseAustralia
Clinical Trials on Tomato products
-
Fundació Institut de Recerca de l'Hospital de la...Completed
-
Clinical Nutrition Research Center, Illinois Institute...Tomato Products Wellness CouncilCompleted
-
Northumbria UniversityCompleted
-
Finnish Institute for Health and WelfareUniversity of Oslo; Academy of Finland; The Finnish Funding Agency for Technology... and other collaboratorsCompletedInflammation | Blood Pressure | Platelet FunctionFinland
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes Mellitus, Type 2 | PreDiabetesSingapore
-
Centre Hospitalier Universitaire DijonUnknown
-
University of ExeterNIHR Exeter Clinical Research Facility; Marlow Foods LtdCompleted
-
Stanford UniversityCompletedCardiovascular Diseases | Microbiome | Immune FunctionUnited States
-
Laval UniversityRecruiting
-
Catholic University of the Sacred HeartCompletedFood Hypersensitivity | Food Allergy | Nickel SensitivityItaly